| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |